The Afinity Collamer aspheric single piece Intraocular Lens (IOL) Model CC4204A and the Elastimide Silicone aspheric IOL Model AQ2015A, both manufactured and marketed by STAAR Surgical, have been designated New Technology IOLs (NTIOLs) by the US Centers for Medicare and Medicaid.
The Afinity Collamer aspheric single piece Intraocular Lens (IOL) Model CC4204A and the Elastimide Silicone aspheric IOL Model AQ2015A, both manufactured and marketed by STAAR Surgical, have been designated New Technology IOLs (NTIOLs) by the US Centers for Medicare and Medicaid. STAAR also already has NTIOL status for the Collamer aspheric three-piece IOL.
NTIOL status, granted if an IOL is able to demonstrate that it provides new clinical benefits, enhances access to the latest IOL technologies to beneficiaries of the Medicare/Medicaid programmes in the US by conferring an additional reimbursement of $50 for each NTIOL provided to these beneficiaries in an Ambulatory Surgical Center (ASC).
The Afinity Collamer single piece lens, which can be implanted through a 2.2 mm incision with the nanoPOINT Injector System (STAAR Surgical), and the Elastimide Silicone lens belong to the Reduced Spherical Aberrations subset of NTIOLs. The additional reimbursement for which these lenses are now eligible will run until 26 February 2011.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.